Tekla Capital Management LLC Historic Quarter Change: USA Everything Else, New

Tekla Capital Management LLC historic quarter change: USA Everything Else, New

In partnership units, exchange-traded notes and anything else (listed in the US), over 13 quarters from 2013-06-30 to 2016-09-30, Tekla Capital Management LLC opened 13 positions, added to 12, reduced 5 and sold out of 8.

Q2 2016: Stock Mylan NV; Country of operation —; Class Shares; Shares before 0.
Q1 2016: Stock Horizon Pharma plc; Country of operation —; Class Shares; Shares before 0.
Q1 2016: Stock Senior Housing Properties Trust; Country of operation —; Class Shares; Shares before 0.
Q4 2015: Stock Allergan plc; Country of operation —; Class Shares; Shares before 0.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1300336), 13 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-09); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-09); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-13); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-12); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-06); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-01-30); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-05); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-13); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-01-28); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-10-30). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2004-06-30.

Quarter	Stock	Class	Shares after	Share change	Value before	Value after	Value change	Filed
Q2 2016	Mylan NV CUSIP N59465109	Shares	722,552	+722,552	$0	$31,243,000	+$31,243,000	2016-08-12
Q1 2016	Horizon Pharma plc CUSIP G4617B105	Shares	749,900	+749,900	$0	$12,426,000	+$12,426,000	2016-05-09
Q1 2016	Senior Housing Properties Trust CUSIP 81721M109	Shares	670,504	+670,504	$0	$11,995,000	+$11,995,000	2016-05-09
Q4 2015	Allergan plc CUSIP G0177J108	Shares	409,586	+409,586	$0	$127,996,000	+$127,996,000	2016-02-09
Q4 2015	Endo International plc CUSIP G30401106	Shares	286,348	+286,348	$0	$17,530,000	+$17,530,000	2016-02-09
Q4 2015	Foamix Pharmaceuticals Ltd. CUSIP M46135105	Shares	652,145	+652,145	$0	$5,289,000	+$5,289,000	2016-02-09
Q4 2015	Mallinckrodt plc CUSIP G5785G107	Shares	61,900	+61,900	$0	$4,620,000	+$4,620,000	2016-02-09
Q2 2015	Allergan plc CUSIP G0177J108	Shares	343,686	+343,686	$0	$104,295,000	+$104,295,000	2015-08-12
Q2 2015	Foamix Pharmaceuticals Ltd. CUSIP M46135105	Shares	413,800	+413,800	$0	$4,241,000	+$4,241,000	2015-08-12
Q1 2015	Mylan NV CUSIP N59465109	Shares Euro	1,010,105	+1,010,105	$0	$59,950,000	+$59,950,000	2015-05-06
Q3 2014	Senior Housing Properties Trust CUSIP 81721M109	Shares	409,504	+409,504	$0	$8,567,000	+$8,567,000	2014-11-14
Q1 2014	Endo International PLC CUSIP G30401106	Shares	126,215	+126,215	$0	$8,665,000	+$8,665,000	2014-05-13
Q4 2013	Actavis plc CUSIP G0083B108	Shares	205,707	+205,707	$0	$34,559,000	+$34,559,000	2014-01-28

Similar Firms

Firm Name	Country	13F Value	Holdings
Not available yet